POMALYST® (pomalidomide) is a prescription medicine, taken along with the medicine dexamethasone, used to treat people with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.
A single source for access support
Celgene Patient Support provides:
- A single Specialist assigned to help patients in your geographic area
- Assistance with understanding patient insurance coverage for POMALYST
- Information about financial assistance for POMALYST
Depending on your patient’s insurance situation, there are programs and organizations that may help pay for POMALYST.
CELGENE COMMERCIAL CO-PAY PROGRAM
For eligible patients with commercial or private insurance (including healthcare exchanges),* co-pay responsibility for POMALYST is reduced to $25 (subject to annual benefit limit).
CELGENE PATIENT ASSISTANCE PROGRAM (PAP)
For qualified patients who are uninsured or underinsured, POMALYST may be available at no cost.†
INDEPENDENT THIRD-PARTY ORGANIZATIONS
For patients who are unable to afford their medication (including patients with Medicare, Medicaid, or other government-sponsored insurance),‡ independent third-party organizations may be able to help.
*Eligibility requirements and restrictions apply. Please see Terms and Conditions on the Celgene Patient Support®website.
†Patients must meet specified financial and insurance eligibility requirements to qualify for assistance. Please see Eligibility Requirements on the Celgene Patient Support® website.
‡Financial and medical eligibility requirements may vary by organization.
Our Specialists are available to assist with each of the following steps in the insurance approval process for POMALYST.§
- Benefits investigation
- Prior authorization assistance‖
- Appeals assistance‖
§Celgene cannot provide insurance advice or make insurance decisions.
‖Celgene provides a facilitation service and will not provide any medical input into a prior authorization or an appeal.
LEARN MORE ABOUT INSURANCE-RELATED ASSISTANCE